In patients hospitalized for COVID-19, tocilizumab reduces mortality at 28 d.

Lo, Carson K L; Chagla, Zain

Lo, Carson K L; Chagla, Zain.

Afiliación

Lo CKL; McMaster University, Hamilton, Ontario, Canada (C.K.L., Z.C.).
Chagla Z; McMaster University, Hamilton, Ontario, Canada (C.K.L., Z.C.).

Ann Intern Med ; 174(11): JC125, 2021 11.

Article en En | MEDLINE | ID: mdl-34724398

RESUMEN

SOURCE CITATION: WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group; Shankar-Hari M, Vale CL, Godolphin PJ, et al. Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis. JAMA. 2021;326:499-518. 34228774.

Asunto(s)

Tratamiento Farmacológico de COVID-19; Anticuerpos Monoclonales Humanizados/uso terapéutico; Humanos; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: Ann Intern Med Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google